OrthoLazer, a Warsaw based health care entity that has developed an innovative non invasive laser therapy for orthopedic problems has secured $7M for Series A. Its backers remained unknown if the startup disclosed any for the round.
Purpose of Funding
The company plans to use the newly raised funds to:
- Grow markets and serve even more patients all over America.
- Propose new orthopedic wellness therapies for the improvement of the quality of health care.
- Faster its time-to-market to provide best-in-class customer-focused, non-opioid, and minimally invasive pain relief solutions.
Advanced Orthopedic Treatment
OrthoLazer is the company operating in orthopedics led by CEO Rod Mayer and founded by CMO Dr. Scott Sigman The company uses MLS M8 Robotic Laser Therapy which is the FDA cleared therapy. PT provides patients with a successful modality for pain control that is free of opiates, which is important in decreasing inflammation and increasing patient recovery time and adequacy of outcomes for orthopedic injuries.
Impact and Future Plans
OrthoLazer aims to deliver state of art, non surgical, orthopaedic treatment solutions. This Series A funding will allow it to grow the patient population it can serve and stay at the forefront of the emerging opioid-sparing analgesic market.
**To get all USA Startup news Please Visit – https://growwseed.com/category/usa-startup-funding-news/
